Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne J Francart

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 30, 2016
The role of specialty pharmacy drugs in the management of inflammatory diseasesKelly A Mullican, Suzanne J Francart
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|April 26, 2013
Apnea of prematurity: caffeine dose optimizationSuzanne J Francart, Megan K Allen, Jennifer Stegall-Zanation
Journal of Pharmacy Practice|March 2, 2021
Embedding an Advanced Pharmacy Technician in an Adult Specialty Pulmonary Clinic to Complete Prior Authorizations Improves Efficiency and Provider SatisfactionEmily M Jones, Suzanne J Francart, Lindsey B Amerine
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 3, 2023
Establishing a pharmacy revenue integrity team: A blueprint for increasing pharmacy's role in health-system revenue cycleJohn Killian L Rodgers, Suzanne J Francart, Lindsey B Amerine
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 30, 2020
Impact of embedded medication assistance program specialists on medication access in outpatient oncology clinicsSeyram S Fudzie, Brandon Luong, Stephanie J Jean, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 18, 2021
A proactive medical necessity review program reduces revenue loss associated with outpatient medical benefit drugsEmily M Hawes, Caron P Misita, Lindsey B Amerine, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 24, 2025
Bridging the continuity: Practice-enhancing publications about the ambulatory care medication-use process in 2023Nicholas P Gazda, Tyler A Vest, Grayson K Peek, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 21, 2025
Bridging the continuity: Practice-enhancing publications about the ambulatory care medication-use process in 2024Nicholas P Gazda, Grayson K Peek, Tyler A Vest, et al.
The Annals of Pharmacotherapy|April 10, 2015
Heparin-Calibrated Chromogenic Anti-Xa Activity Measurements in Patients Receiving Rivaroxaban: Can This Test Be Used to Quantify Drug Level?Robert C Gosselin, Suzanne J Francart, Emily M Hawes, et al.
Archives of Pathology & Laboratory Medicine|November 27, 2014
Comparison of anti-Xa and dilute Russell viper venom time assays in quantifying drug levels in patients on therapeutic doses of rivaroxabanRobert C Gosselin, Dorothy M Adcock Funk, J Michael Taylor, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 30, 2016
The role of specialty pharmacy drugs in the management of inflammatory diseasesKelly A Mullican, Suzanne J Francart
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|April 26, 2013
Apnea of prematurity: caffeine dose optimizationSuzanne J Francart, Megan K Allen, Jennifer Stegall-Zanation
Journal of Pharmacy Practice|March 2, 2021
Embedding an Advanced Pharmacy Technician in an Adult Specialty Pulmonary Clinic to Complete Prior Authorizations Improves Efficiency and Provider SatisfactionEmily M Jones, Suzanne J Francart, Lindsey B Amerine
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 3, 2023
Establishing a pharmacy revenue integrity team: A blueprint for increasing pharmacy's role in health-system revenue cycleJohn Killian L Rodgers, Suzanne J Francart, Lindsey B Amerine
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 30, 2020
Impact of embedded medication assistance program specialists on medication access in outpatient oncology clinicsSeyram S Fudzie, Brandon Luong, Stephanie J Jean, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 18, 2021
A proactive medical necessity review program reduces revenue loss associated with outpatient medical benefit drugsEmily M Hawes, Caron P Misita, Lindsey B Amerine, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 24, 2025
Bridging the continuity: Practice-enhancing publications about the ambulatory care medication-use process in 2023Nicholas P Gazda, Tyler A Vest, Grayson K Peek, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 21, 2025
Bridging the continuity: Practice-enhancing publications about the ambulatory care medication-use process in 2024Nicholas P Gazda, Grayson K Peek, Tyler A Vest, et al.
The Annals of Pharmacotherapy|April 10, 2015
Heparin-Calibrated Chromogenic Anti-Xa Activity Measurements in Patients Receiving Rivaroxaban: Can This Test Be Used to Quantify Drug Level?Robert C Gosselin, Suzanne J Francart, Emily M Hawes, et al.
Archives of Pathology & Laboratory Medicine|November 27, 2014
Comparison of anti-Xa and dilute Russell viper venom time assays in quantifying drug levels in patients on therapeutic doses of rivaroxabanRobert C Gosselin, Dorothy M Adcock Funk, J Michael Taylor, et al.
Pageof 2